Enhancement of neutralization of Sindbis, Venezuelan equine encephalitis, Eastern equine encephalitis, Western equine encephalitis, and St. Louis encephalitis viruses by labile serum factor (LSF) in human serum and plasma was demonstrated. Human serum and plasma could be diluted 1:8 and 1:16 and still retain some LSF activity. Satisfactory storage temperatures for retention of LSF activity were -20 or -56 C. Repeated freeze-thaw cycles of serum did not alter LSF activity, but the activity was completely eliminated by heating at 56 C for 5 min. LSF of human serum equally enhanced neutralization by Sindbis immune mouse and rabbit sera; these results suggest a lack of species specificity. Rehydrated lyophilized gunea pig complement did not restore LSF activity to heated human plasma. Serum components responsible for LSF activity were not dialyzable. Discovery of fresh serum without LSF activity established the need to pretest all sera used as LSF sources. (EEE) virus (NJO strain) was passed six times. These viruses were prepared as 20% suspensions of suckling mouse brain in phosphate-buffered saline containing 4.0% bovine plasma albumin, pH 7.8. After lyophilization, these virus seeds were stored at -20 C.
The observations of many investigators have established without doubt that fresh serum enhances neutralization of a variety of viruses by homologous antisera (1, 4, 5, 7, (EEE) virus (NJO strain) was passed six times. These viruses were prepared as 20% suspensions of suckling mouse brain in phosphate-buffered saline containing 4.0% bovine plasma albumin, pH 7.8. After lyophilization, these virus seeds were stored at -20 C.
St. Louis encephalitis (SLE) virus (strain TBH-28) was passed three times in suckling mice by the ic route and one time in HeLa cells. The SLE virus seed consisted of HeLa cell culture fluid harvested at the peak of cytopathic effect (CPE). An attenuated vaccine strain (TC-83) of Venezuelan equine encephalitis (VEE) virus was used. Seed virus of VEE was prepared in primary guinea pig heart cell cultures; in total, 84 passages were made in these cells. Fluid was harvested from these cultures at the peak of CPE and used as virus seed. Wet-frozen seeds of SLE and VEE viruses were stored at -56 C.
Serum and plasma. Immune rabbit sera were produced in New Zealand white rabbits by multiple injections of mouse brain vaccine. Infectious brain tissue was used for Sindbis, EEE, WEE, and SLE vaccine; however, the VEE vaccine was inactivated with beta-propiolactone. Sera and plasma from human donors were screened for neutralizing antibody to several viruses including Sindbis, VEE, EEE, WEE, and SLE. Serum and plasma samples free from antibody to these viruses were dispensed in vials and stored at -56 C as soon as possible after collection. Sindbis-immune mouse ascitic fluid was prepared by the method of Tikasingh et al. (20) . The diluent used for serum, plasma, and ascitic fluid samples was I x Hanks balanced salt solution (HBSS) as described by Hanks and Wallace (10 Cell cultures. Primary cell cultures of embryonic duck cells were prepared from 13-day-old Pekin duck embryos by using a procedure similar to one described by Hsiung (13) . Stock 10% cell suspensions were stored at 5 C until used. This suspension could be stored for 5 days without medium change and for 10 days with a change of medium every 2 days.
For plaque assay, the stock cell suspension was diluted 1:20 with growth medium. One-ounce (ca. 30 ml) prescription bottles (Sani-Glas), with rubberlined caps, were planted with 4 ml of cell suspension. Cultures were grown for 2 days at 35 to 37 C before inoculation.
Plaque assay procedure. Spent medium was discarded from confluent cultures, and each bottle was inoculated with 0.1 ml of virus suspension. Two cultures were inoculated with each virus dilution and were incubated at 35 C for 1 hr for virus adsorption.
To each bottle was added 4 ml of agar overlay medium. This medium contained the same ingredients as those described by Hsiung for chick embryo cell cultures (13) . Bottles were incubated at 35 C. Plaque-forming-unit (PFU) titers were based on the mean plaque number in all bottles containing 10 to 100 plaques.
Neutralization test. Tenfold dilutions of virus were made both in unheated serum and in serum that had been heated to 56 C for 30 min. Normal control and immune test sera and ascitic fluids were diluted 1:10 with HBSS and dispensed into tubes. These were heated at 56 C for 30 min to reduce native LSF to uniform levels. An equal volume of diluted virus was added to each serum or ascitic fluid sample, and these mixtures were incubated at 37 C for 1 hr. Two cell cultures were inoculated with 0.1 ml of each serum-virus mixture.
RESULTS
Effect of dilution on LSF activity of human serum. Sera from two human donors were diluted LL El P AL.
APPL. MICROBIOL. test. Complete loss of LSF occurred when serum was heated for only 5 min. Samples of human serum diluted 1:8 were stored at 24, 4, -20, and -56 C for 57 days and tested periodically to determine the stability of LSF at these temperatures. As shown in Table 2 , the neutralization-enhancing effect of LSF was still present in serum stored at 24 C for 8 days but was absent at 15 days. Serum stored at 4 C for 22 days enhanced Sindbis neutralization; however, after 57 days the effect was considerably diminished. Serum stored at -20 and -56 C for 57 days showed no loss in LSF activity. One serum, not tabulated, retained LSF activity for at least 204 days while stored at -56C.
Effect of freezing and thawing. Human serum diluted 1:8 in HBSS and frozen and thawed 10 times revealed no loss in LSF activity as a result of this treatment. A gradual decrease in pH occurred during the freeze-thaw cycles but had no apparent effect on the neutralization results.
Effect of LSF on neutralizaton activity of immune sera from different species. Human serum diluted 1:8 was used as virus diluent in Sindbis neutralization tests with immune rabbit serum and immune mouse ascitic fluid. Since the neutralization activity of both of these immune sera was equally enhanced, these results suggest a lack of species specificity of LSF.
Effect of LSF on neutralization of several different arboviruses. Neutralization tests were carried out with VEE, EEE, WEE, and SLE viruses by using immune rabbit sera and normal rabbit serum. Sindbis virus neutralization was done simultaneously to provide a base line of LSF activity. Virus dilutions were made in normal human serum that had been stored at -56 C for 204 days and diluted 1:8. The results (Table 3) indicate enhanced neutralization of all five arboviruses.
Effect of guinea pig complement on Sindbis neutralization. Lyophilized guinea pig complement was reconstituted and tested at dilutions of 1:5, 1:50, and 1:500 to determine its effect on neutralization of Sindbis virus by immune rabbit serum, as compared with undiluted human plasma. There was little if any enhancement of neutralization by the complement.
The same concentrations of guinea pig complement were mixed with heat-inactivated human plasma to determine whether it would restore the lost LSF activity of the plasma. No restoration of neutralization-enhancing activity was observed.
Effect of dialysis on LSF. Undiluted human serum was dialyzed overnight and then diluted 1:8 and tested for LSF activity by the Sindbis neutralization system. Dialyzed and undialyzed sera enhanced neutralization of Sindbis virus equally.
DISCUSSION
Some laboratories use normal serum routinely in virus neutralization tests as a source of LSF, whereas other laboratories almost never use normal serum. Whether normal serum is used is often determined by the availability of suitable serum; it must be free from neutralizing antibodies and nonspecific inhibitors of the viruses being tested. Furthermore, it must contain detectable LSF.
As pointed out by Allen et al. (2) in their re-81 VOL. 21, 1971 on January 26, 2018 by guest http://aem.asm.org/ Downloaded from view of viral inhibitors in normal sera, many investigators routinely heat-inactivate serum specimens before testing them for neutralizing antibody, but others do not. It is well established that serum must be heat-inactivated for use in the complement fixation test; however, the necessity for heat-inactivating serum before testing for virus-neutralizing antibodies is not uniformly recognized. The reasons for heating are several: to remove nonspecific viral inhibitors, to inactivate infectious virus in serum collected during viremia, and to inactivate labile components that may irregularly enhance virus neutralization. Concerning the latter, improper storage of paired diagnostic specimens before testing may cause loss of natural LSF from the first specimen, but not the second, and may cause a false-positive result.
Hammon and Work (9) discussed the importance of LSF in sera being tested for arbovirus-neutralizing antibodies. They pointed out the necessity of LSF to sera that have been stored under various conditions before being tested. For uniformity, there appears to be a definite advantage in heat-inactivating such sera before adding LSF.
Obtaining large volumes of normal serum often is difficult, and checking the serum to confirm usable LSF activity and absence of conflicting antibodies is time consuming; it is, therefore, a matter of simple economy to know how much the serum can be diluted and still retain LSF activity. Our studies indicated no loss in activity of normal human serum at a 1:4 dilution and very little at 1:8. Certainly, use of a 1:5 dilution rather than undiluted serum appears warranted. These findings are in accord with those of others (9) who have reported that LSF begins to lose effectiveness between dilutions of 1:5 and 1:10. We have found in concurrent studies that human plasma can be diluted up to 1:10 without detectable loss in LSF activity. Although human plasma can be used in place of serum as a source of LSF, some problems are encountered; plasma clot formation may occur during serum-virus incubation. Although these clots do not appear to alter neutralization enhancement, they occasionally disrupt cell monolayers in plaque assay bottles.
The term "fresh serum," as used by investigators in discussing its effect on virus neutralization, has been undefined in most reports. It is important to know how to store normal serum for maxium retention of LSF activity. The results of our studies indicate no loss in activity at either -20 or -56 C for at least 2 months; in fact, at the latter temperature no loss was noted for 204 days. Since no appreciable loss in activity occurred during 8 days at room temperature and during 22 days at 4 C, the necessity for rapid processing of normal serum for freezing is not as great as previously assumed. This allows for a more relaxed scheduling of laboratory work load. It is also apparent that serum to be used as an accessory factor can be frozen in bulk if desired, since freezing and thawing for at least 10 times have been shown not to alter LSF activity.
The common practice is to heat-inactivate serum specimens at 56 C for 30 min to level off LSF activity. It appears that this time period is excessive, since, in our tests, heating at this temperature for 5 min was as effective as 1 hr.
Our studies did not include immune sera of enough animal species to prove lack of specificity of normal serum for LSF activity; however, identical results were obtained when human serum LSF was used with immune rabbit serum and with immune mouse ascitic fluid. These are the two most frequently used antibody preparations in arbovirus laboratories.
Enhancement of neutralization by LSF was clearly demonstrated for five different arboviruses. These results confirm earlier reports on enhanced neutralization of EEE (7) and WEE (4, 5, 16, 22) viruses by normal fresh serum.
Several investigators have shown that fresh guinea pig serum enhances virus neutralization (15, 17, 19) ; others have been unable to demonstrate such enhancement (6, 11) . It has been suggested that complement is the labile serum component responsible for enhancement of neutralization (4, 15, 16) . However, Howitt (12) found that fresh guinea pig complement had no effect on the neutralization of WEE virus by immune horse serum. Our results are in accord with those of Howitt since complement did not restore lost LSF activity to heated human plasma.
Although we do not know the chemical nature of LSF, its ability to pass a cellophane membrane is indicative of a molecular weight of >25,000 (3) .
At the beginning of this study, we assumed that any human serum free from antibodies to the viruses of interest would be a satisfactory source of LSF if stored properly. This assumption is not necessarily correct. No LSF could be detected in two of the serum specimens tested in our study, despite the fact that these two specimens were from a donor whose serum several months earlier had exhibited LSF activity. This finding indicates the advisability of pretesting all sera used as a source of LSF for LSF activity as well as for freedom from specific antibodies. The absence of LSF in some sera may account for confusing reports concerning the enhancing effect of fresh serum. 
